{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,20]],"date-time":"2026-08-20T15:00:10Z","timestamp":1787238010303,"version":"build-2736575974"},"reference-count":50,"publisher":"Wiley","issue":"4","license":[{"start":{"date-parts":[[2022,1,17]],"date-time":"2022-01-17T00:00:00Z","timestamp":1642377600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"funder":[{"DOI":"10.13039\/100016879","name":"Union Chimique Belge","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100016879","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["onlinelibrary.wiley.com"],"crossmark-restriction":true},"short-container-title":["Epilepsia"],"published-print":{"date-parts":[[2022,4]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Objectives<\/jats:title>\n                    <jats:p>There is no effective therapy to prevent the development of posttraumatic epilepsy (PTE). Recently, we reported that administration of the antiseizure medication (ASM) levetiracetam (LEV) shortly after trauma prevented the development of epileptiform activity in two experimental models of neurotrauma. However, the time window for effective intervention with LEV may be too narrow for most clinical settings. Using the controlled cortical impact (CCI) injury model, the current study tested whether early administration of brivaracetam (BRV), an ASM with 20 times the affinity of LEV for the SV2A synaptic vesicle protein, could improve upon the antiepileptogenic action observed with LEV.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>Rats (postnatal day [P] 24\u201332) subjected to CCI injury were given a single dose of BRV (21 or 100\u00a0mg\/kg, i.p.) at one of three post\u2010injury time points: immediately (0\u20132\u00a0minutes), 30 minutes, or 60\u00a0minutes. Control animals received only vehicle (0.9% saline). Posttraumatic electrographic epileptiform activity was assayed ex vivo from coronal neocortical slices collected proximal to the injury (four per rat) 3\u20134\u00a0weeks after injury. In this model, ictal\u2010like burst discharges occur spontaneously or can be evoked in an \u201call or none\u201d manner with applied electrical stimulation within the first 2\u00a0weeks after injury.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>A single dose of BRV administered to rats up to 60\u00a0minutes after traumatic brain injury (TBI) significantly reduced the development of posttraumatic epileptiform activity by (1) inhibiting the development of both evoked and spontaneous epileptiform activity, (2) raising the threshold for stimulus\u2010evoked epileptiform discharges, and (3) reducing the intensity of epileptiform bursts that arise after cortical neurotrauma.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Significance<\/jats:title>\n                    <jats:p>Clinically there has been little success preventing the development of posttraumatic epilepsy. The results of this study support the hypothesis that early intervention with BRV has the potential to prevent or reduce posttraumatic epileptogenesis, and that there may be a limited time window for successful prophylactic intervention.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1111\/epi.17167","type":"journal-article","created":{"date-parts":[[2022,1,17]],"date-time":"2022-01-17T05:49:17Z","timestamp":1642398557000},"page":"992-1002","update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":7,"title":["Brivaracetam prevents the development of epileptiform activity when administered early after cortical neurotrauma in rats"],"prefix":"10.1111","volume":"63","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-2466-164X","authenticated-orcid":false,"given":"Douglas S. F.","family":"Ling","sequence":"first","affiliation":[{"name":"Departments of Physiology and Pharmacology SUNY Downstate Health Sciences University  Brooklyn New York USA"},{"name":"Robert F. Furchgott Center for Behavioral and Neural Science SUNY Downstate Health Sciences University  Brooklyn New York USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4329-0282","authenticated-orcid":false,"given":"Lie","family":"Yang","sequence":"additional","affiliation":[{"name":"Departments of Physiology and Pharmacology SUNY Downstate Health Sciences University  Brooklyn New York USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6001-8040","authenticated-orcid":false,"given":"Jeffrey H.","family":"Goodman","sequence":"additional","affiliation":[{"name":"Departments of Physiology and Pharmacology SUNY Downstate Health Sciences University  Brooklyn New York USA"},{"name":"Robert F. Furchgott Center for Behavioral and Neural Science SUNY Downstate Health Sciences University  Brooklyn New York USA"},{"name":"Department of Neurology SUNY Downstate Health Sciences University  Brooklyn New York USA"},{"name":"Department of Developmental Neurobiology The New York State Institute for Basic Research in Developmental Disabilities  Staten Island New York USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2022,1,17]]},"reference":[{"key":"e_1_2_8_2_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.neuropharm.2019.107762"},{"key":"e_1_2_8_3_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.neuropharm.2019.04.011"},{"key":"e_1_2_8_4_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1535-7511.2005.00083.x"},{"key":"e_1_2_8_5_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199008233230801"},{"key":"e_1_2_8_6_1","doi-asserted-by":"publisher","DOI":"10.3171\/jns.1999.91.4.0593"},{"key":"e_1_2_8_7_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1528-1167.2008.02005.x"},{"key":"e_1_2_8_8_1","doi-asserted-by":"publisher","DOI":"10.1007\/s13311-013-0252-z"},{"key":"e_1_2_8_9_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.nbd.2018.06.017"},{"key":"e_1_2_8_10_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.expneurol.2020.113571"},{"key":"e_1_2_8_11_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1499-1654.2000.001507.x"},{"key":"e_1_2_8_12_1","doi-asserted-by":"publisher","DOI":"10.3171\/jns.1998.89.6.0971"},{"key":"e_1_2_8_13_1","doi-asserted-by":"publisher","DOI":"10.3171\/2009.12.JNS09689"},{"key":"e_1_2_8_14_1","doi-asserted-by":"publisher","DOI":"10.1089\/neu.2015.4373"},{"key":"e_1_2_8_15_1","doi-asserted-by":"publisher","DOI":"10.1186\/1742-2094-8-67"},{"key":"e_1_2_8_16_1","doi-asserted-by":"publisher","DOI":"10.1007\/s11910-015-0545-1"},{"key":"e_1_2_8_17_1","doi-asserted-by":"publisher","DOI":"10.1126\/science.2567056"},{"key":"e_1_2_8_18_1","doi-asserted-by":"publisher","DOI":"10.1093\/cercor\/bhu041"},{"key":"e_1_2_8_19_1","doi-asserted-by":"publisher","DOI":"10.1038\/bjp.2008.198"},{"key":"e_1_2_8_20_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejphar.2011.04.064"},{"key":"e_1_2_8_21_1","doi-asserted-by":"publisher","DOI":"10.1111\/epi.14532"},{"key":"e_1_2_8_22_1","doi-asserted-by":"publisher","DOI":"10.1089\/neu.2006.0011"},{"key":"e_1_2_8_23_1","doi-asserted-by":"publisher","DOI":"10.1089\/089771501317095232"},{"key":"e_1_2_8_24_1","doi-asserted-by":"publisher","DOI":"10.1089\/neu.2009.1244"},{"key":"e_1_2_8_25_1","doi-asserted-by":"publisher","DOI":"10.1152\/jn.1995.74.6.2329"},{"key":"e_1_2_8_26_1","doi-asserted-by":"publisher","DOI":"10.1152\/jn.1997.78.5.2804"},{"key":"e_1_2_8_27_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0304-3940(98)00798-8"},{"key":"e_1_2_8_28_1","volume-title":"Statistics for experimenters: an introduction to design, data analysis, and model building","author":"Box GEP","year":"1978"},{"key":"e_1_2_8_29_1","doi-asserted-by":"publisher","DOI":"10.1016\/0006-8993(73)90647-1"},{"key":"e_1_2_8_30_1","doi-asserted-by":"publisher","DOI":"10.1016\/0014-4886(64)90025-1"},{"key":"e_1_2_8_31_1","doi-asserted-by":"publisher","DOI":"10.1016\/0014-4886(68)90066-6"},{"key":"e_1_2_8_32_1","doi-asserted-by":"publisher","DOI":"10.1111\/epi.12973"},{"key":"e_1_2_8_33_1","doi-asserted-by":"publisher","DOI":"10.1111\/epi.13787"},{"key":"e_1_2_8_34_1","doi-asserted-by":"publisher","DOI":"10.3389\/fneur.2013.00170"},{"key":"e_1_2_8_35_1","doi-asserted-by":"publisher","DOI":"10.1089\/neu.2009.1238"},{"key":"e_1_2_8_36_1","doi-asserted-by":"publisher","DOI":"10.1161\/hs1001.097242"},{"key":"e_1_2_8_37_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.nicl.2019.102069"},{"key":"e_1_2_8_38_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1528-1167.2006.01132.x"},{"key":"e_1_2_8_39_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.seizure.2009.07.004"},{"key":"e_1_2_8_40_1","doi-asserted-by":"publisher","DOI":"10.1152\/jn.00279.2011"},{"key":"e_1_2_8_41_1","doi-asserted-by":"publisher","DOI":"10.1097\/WNR.0000000000000601"},{"key":"e_1_2_8_42_1","doi-asserted-by":"publisher","DOI":"10.1021\/jm030913e"},{"key":"e_1_2_8_43_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1742-7843.2009.00536.x"},{"key":"e_1_2_8_44_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.eplepsyres.2009.09.024"},{"key":"e_1_2_8_45_1","doi-asserted-by":"publisher","DOI":"10.1111\/epi.13890"},{"key":"e_1_2_8_46_1","doi-asserted-by":"publisher","DOI":"10.1002\/ana.20124"},{"key":"e_1_2_8_47_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.neures.2008.08.005"},{"key":"e_1_2_8_48_1","doi-asserted-by":"publisher","DOI":"10.1089\/neu.2018.6162"},{"key":"e_1_2_8_49_1","doi-asserted-by":"publisher","DOI":"10.1089\/neu.2012.2712"},{"key":"e_1_2_8_50_1","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0064078"},{"key":"e_1_2_8_51_1","unstructured":"LingDSF YangL&GoodmanJHPrevention of posttraumatic epileptogenesis by brivaracetam in the CCI model of traumatic brain injury in rats. AES 2019 Annual Meeting Abstract Database. AESnet.org. 2019:2.260."}],"container-title":["Epilepsia"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/epi.17167","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/full-xml\/10.1111\/epi.17167","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/epi.17167","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,8,23]],"date-time":"2023-08-23T23:12:58Z","timestamp":1692832378000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/epi.17167"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,1,17]]},"references-count":50,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2022,4]]}},"alternative-id":["10.1111\/epi.17167"],"URL":"https:\/\/doi.org\/10.1111\/epi.17167","archive":["Portico"],"relation":{},"ISSN":["0013-9580","1528-1167"],"issn-type":[{"value":"0013-9580","type":"print"},{"value":"1528-1167","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,1,17]]},"assertion":[{"value":"2021-09-07","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2022-01-04","order":1,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2022-01-17","order":2,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}